Wednesday, July 20, 2022 3:54:53 PM
Revenue growth in 2021 was 35% and it is already up a further 20% in 2022.
We already know that Q2 will be as good or better than Q1 after $1.29M sales in June.
Q3 is already off to a good start with $492K in revenue in just 2 weeks and Week 29 looking like it will be in the $250K > $300K+ range.
Master DD here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169421389
Full career military veteran now spotting & trading stocks $.0001 to $1. Not a financial advisor. Do your own DD.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM